NL-OMON31594已完成4 期
Effect of inhalation of tiotropium once daily 18 mcg versus salmeterol twice daily 50 mcg on time to first exacerbation in COPD patients (a randomized, double-blind, double-dummy, parallel group, one year study) - POET
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Current or ex-smoker, 40 years of age or older, diagnosed with COPD with at least one exacerbation within the past year requiring treatment.
- •Patients must have a post-bronchodilator FEV1 <= 70% of predicted normal and FEV1 <= 70% of FVC post-bronchodilator.
排除标准
- •Patients with cardiac-related conditions, significant diseases other than COPD and other concomitant conditions and therapies that will have an impact on the wellbeing of the patient or may influence either the result of the study or the patients' ability to participate in the study.
研究者
相似试验
进行中（未招募）
1 期
Effect of inhalation of tiotropium once daily 18 mcg versus salmeteroltwice daily 50 mcg on time to first exacerbation in COPD patients (arandomised, double-blind, double-dummy, parallel group, one-yearstudy). - POETEUCTR2007-001840-33-FRBoehringer Ingelheim Pharma GmbH & Co. KG6,800
进行中（未招募）
不适用
Effect of inhalation of tiotropium once daily 18 mcg versus salmeteroltwice daily 50 mcg on time to first exacerbation in COPD patients (arandomised, double-blind, double-dummy, parallel group, one-yearstudy). - POETchronic obstructive pulmonary disease (COPD)MedDRA version: 9.1Level: LLTClassification code 10010952Term: COPDEUCTR2007-001840-33-HUBoehringer Ingelheim Pharma GmbH & Co. KG7,350
进行中（未招募）
不适用
Effect of inhalation of tiotropium once daily 18 mcg versus salmeteroltwice daily 50 mcg on time to first exacerbation in COPD patients (arandomised, double-blind, double-dummy, parallel group, one-yearstudy). - POETEUCTR2007-001840-33-BGBoehringer Ingelheim Pharma GmbH & Co. KG7,350
进行中（未招募）
不适用
Effect of inhalation of tiotropium once daily 18 mcg versus salmeterol twice daily 50 mcg on time to first exacerbation in COPD patients (a randomised, double-blind, double-dummy, parallel group, one-year study)COPDMedDRA version: 14.1Level: PTClassification code 10061877Term: Obstructive airways disorderSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2007-001840-33-ITBOEHRINGER ING.6,800
进行中（未招募）
1 期
Effect of inhalation of tiotropium once daily 18 mcg versus salmeteroltwice daily 50 mcg on time to first exacerbation in COPD patients (arandomised, double-blind, double-dummy, parallel group, one-yearstudy).Efecto de la inhalación de 18 microgramos de tiotropio una vez al día frente a 50 microgramos de salmeterol dos veces al día sobre el tiempo hasta la primera exacerbación en pacientes con EPOC (estudio de un año de duración, aleatorizado, en doble ciego, con doble simulación y de grupos paralelos). - POETEUCTR2007-001840-33-ESBoehringer Ingelheim Pharma GmbH & Co. KG6,800